Pharmacotherapy for Obesity: Past, Present and Future
- 30 June 2010
- journal article
- review article
- Published by Elsevier in Journal of Experimental & Clinical Medicine
- Vol. 2 (3) , 118-123
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Drug treatments for obesity: orlistat, sibutramine, and rimonabantThe Lancet, 2007
- Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight LossCirculation, 2006
- National Trends in Antiobesity Medication UseArchives of internal medicine (1960), 2003
- Obesity Drug Pipeline Not So Fat2003
- Use of Ephedra -containing products and risk for hemorrhagic strokeNeurology, 2003
- Use of Nonprescription Weight Loss ProductsJAMA, 2001
- Use of Prescription Weight Loss Pills among U.S. Adults in 1996–1998Annals of Internal Medicine, 2001
- Phenylpropanolamine and the Risk of Hemorrhagic StrokeNew England Journal of Medicine, 2000
- Executive Summary of the Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in AdultsArchives of internal medicine (1960), 1998
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997